J. Evans

发表

Platelet activating factor does not cause a reproducible increase in bronchial responsiveness in normal man

P. Piper, J. Costello, S. Green, 1990, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Plasma albumin concentrations and intestinal permeability in Bangladeshi children infected with Ascaris lumbricoides.

P. Lunn, M. Wainwright, C. Northrop, 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Participation of the cysteinyl leukotrienes in the acute bronchoconstrictor response to inhaled platelet activating factor in man.

P. Piper, J. Costello, D. Spencer, 1991, Thorax.

inhaled platelet activating factor in man . the acute bronchoconstrictor response to Participation of the cysteinyl leukotrienes in

P. Piper, J. Costello, D. Spencer, 2022 .

L-648,051, a novel cysteinyl-leukotriene antagonist is active by the inhaled route in man.

J. Zakrzewski, N. Barnes, D. Sciberras, 1989, British journal of clinical pharmacology.

Pharmacology and Physiology of Leukotrienes and Their Antagonists a

J. Zakrzewski, N. Barnes, P. Piper, 1988, Annals of the New York Academy of Sciences.

The generation and metabolism of leukotrienes in the ionophore-stimulated blood of normal and asthmatic subjects.

A. Sampson, P. Piper, J. Costello, 1990, Pulmonary pharmacology.

The biotransformation in vitro of cysteinyl leukotrienes in blood of normal and asthmatic subjects.

J. Zakrzewski, N. Barnes, A. Sampson, 1989, Prostaglandins.

Leukotrienes and Inflammatory Lung Disease

C. P. Green, J. Price, A. Sampson, 1991, Annals of the New York Academy of Sciences.

Theophylline--an immunomodulatory role in asthma?

C. Page, J. Costello, A. J. Ward, 1993, The American review of respiratory disease.

Leukotrienes in the Lung and Cardiovascular System

N. Barnes, P. Piper, J. Costello, 1989 .

The metabolism "in vitro" of leukotriene B4 in blood of normal subjects and asthmatic patients.

J. Zakrzewski, N. Barnes, A. Sampson, 1988, Prostaglandins.

Bronchial responsiveness is not always increased after allergen challenge.

C. Page, J. Costello, A. J. Ward, 1994, Respiratory medicine.

The pharmacological profile of SK&F 104353-Z2, a potent, selective inhaled antagonist of cysteinyl leukotrienes, in normal man.

P. Piper, J. Costello, J. Evans, 1991, Advances in prostaglandin, thromboxane, and leukotriene research.

A critical evaluation of the clinical relevance of leukotrienes in bronchial asthma.

J. Zakrzewski, N. Barnes, P. Piper, 1989, Agents and actions. Supplements.

A clinically relevant modification to existing inhaler therapy.

J. Moxham, D. Ganderton, A. J. Ward, 1992, Respiratory medicine.

Participation of the cysteinyl leukotrienes in the acute bronchoconstrictor response to inhaled platelet activating factor in man.

P. Piper, J. Costello, D. Spencer, 1991, Thorax.

The acute effects of respiratory manoeuvres in post-operative patients

J. Moxham, S. Jenkins, J. Evans, 1988 .